1. Home
  2. TPVG vs NYXH Comparison

TPVG vs NYXH Comparison

Compare TPVG & NYXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TPVG
  • NYXH
  • Stock Information
  • Founded
  • TPVG 2013
  • NYXH 2009
  • Country
  • TPVG United States
  • NYXH Belgium
  • Employees
  • TPVG N/A
  • NYXH N/A
  • Industry
  • TPVG Other Consumer Services
  • NYXH Medical/Dental Instruments
  • Sector
  • TPVG Consumer Discretionary
  • NYXH Health Care
  • Exchange
  • TPVG Nasdaq
  • NYXH Nasdaq
  • Market Cap
  • TPVG 226.6M
  • NYXH 188.1M
  • IPO Year
  • TPVG N/A
  • NYXH 2021
  • Fundamental
  • Price
  • TPVG $5.52
  • NYXH $4.99
  • Analyst Decision
  • TPVG Hold
  • NYXH Strong Buy
  • Analyst Count
  • TPVG 6
  • NYXH 3
  • Target Price
  • TPVG $6.38
  • NYXH $15.00
  • AVG Volume (30 Days)
  • TPVG 271.3K
  • NYXH 43.2K
  • Earning Date
  • TPVG 11-05-2025
  • NYXH 11-13-2025
  • Dividend Yield
  • TPVG 16.85%
  • NYXH N/A
  • EPS Growth
  • TPVG N/A
  • NYXH N/A
  • EPS
  • TPVG 1.03
  • NYXH N/A
  • Revenue
  • TPVG $97,395,000.00
  • NYXH $5,793,306.00
  • Revenue This Year
  • TPVG N/A
  • NYXH $85.62
  • Revenue Next Year
  • TPVG $7.69
  • NYXH $320.09
  • P/E Ratio
  • TPVG $5.30
  • NYXH N/A
  • Revenue Growth
  • TPVG N/A
  • NYXH 2.94
  • 52 Week Low
  • TPVG $5.24
  • NYXH $4.35
  • 52 Week High
  • TPVG $8.50
  • NYXH $11.87
  • Technical
  • Relative Strength Index (RSI)
  • TPVG 38.08
  • NYXH 40.36
  • Support Level
  • TPVG $5.38
  • NYXH $5.00
  • Resistance Level
  • TPVG $5.59
  • NYXH $5.96
  • Average True Range (ATR)
  • TPVG 0.14
  • NYXH 0.24
  • MACD
  • TPVG 0.01
  • NYXH -0.07
  • Stochastic Oscillator
  • TPVG 13.05
  • NYXH 11.90

About TPVG TriplePoint Venture Growth BDC Corp.

TriplePoint Venture Growth BDC Corp is a closed-end, non-diversified management investment company. Its investment objective is to maximize its total return to stockholders in the form of current income and, to a lesser extent, capital appreciation. The fund focuses on companies operating in the fields of biofuels, business applications software, wireless communications equipment, e-commerce, clothing and accessories, conferencing equipment and services, personal goods, financial institutions and services, entertainment, mixed retailing, and healthcare services. Geographically, all the operations of the firm function through the region of the United states.

About NYXH Nyxoah SA

Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.

Share on Social Networks: